• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喷雾干燥布洛芬-硅微球中的药物纳米域。

Drug nano-domains in spray-dried ibuprofen-silica microspheres.

机构信息

Institut Charles Gerhardt de Montpellier, ICGM-MACS, UMR 5253 CNRS-ENSCM-UM2-UM1, 8 rue de l'Ecole Normale, 34296 Montpellier cedex 5, France.

出版信息

Phys Chem Chem Phys. 2012 Sep 21;14(35):12285-94. doi: 10.1039/c2cp42092a. Epub 2012 Aug 7.

DOI:10.1039/c2cp42092a
PMID:22868488
Abstract

Silica microspheres encapsulating ibuprofen in separated domains at the nanometre scale are formed by spray-drying and sol-gel processes. A detailed (1)H and (13)C NMR study of these microspheres shows that ibuprofen molecules are mobile and are interacting through hydrogen bonds with other ibuprofen molecules. (1)H magnetisation exchange NMR experiments were employed to characterize the size of the ibuprofen domains at the nanometre scale. These domains are solely formed by ibuprofen, and their diameters are estimated to be ∼40 nm in agreement with TEM observations. The nature and formation of these particular texture and drug dispersion are discussed.

摘要

通过喷雾干燥和溶胶-凝胶工艺形成了在纳米尺度上分离的域内包埋布洛芬的二氧化硅微球。对这些微球的详细的 (1)H 和 (13)C NMR 研究表明,布洛芬分子是可移动的,并通过氢键与其他布洛芬分子相互作用。采用 (1)H 磁化交换 NMR 实验来表征纳米尺度上布洛芬域的大小。这些域仅由布洛芬形成,其直径估计为 ∼40nm,与 TEM 观察结果一致。讨论了这种特殊纹理和药物分散的性质和形成。

相似文献

1
Drug nano-domains in spray-dried ibuprofen-silica microspheres.喷雾干燥布洛芬-硅微球中的药物纳米域。
Phys Chem Chem Phys. 2012 Sep 21;14(35):12285-94. doi: 10.1039/c2cp42092a. Epub 2012 Aug 7.
2
Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.介孔硅共喷雾干燥制备布洛芬的物理状态和溶解性能:孔和粒径的影响。
Int J Pharm. 2011 May 30;410(1-2):188-95. doi: 10.1016/j.ijpharm.2011.03.018. Epub 2011 Mar 16.
3
Potential of amorphous microporous silica for ibuprofen controlled release.无定形微孔硅的布洛芬控制释放潜力。
Int J Pharm. 2010 Sep 15;397(1-2):84-91. doi: 10.1016/j.ijpharm.2010.06.053. Epub 2010 Jul 7.
4
Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.通过一步溶胶-凝胶法将药物包封于二氧化硅微球及其体外释放行为
J Biomed Mater Res B Appl Biomater. 2006 Apr;77(1):149-55. doi: 10.1002/jbm.b.30416.
5
Preparation and evaluation of microspheres prepared from novel polyester-ibuprofen conjugates blended with non-conjugated ibuprofen.新型聚酯-布洛芬偶联物与非偶联布洛芬共混微球的制备与评价。
J Microencapsul. 2009 Dec;26(8):676-83. doi: 10.3109/02652040802656333.
6
Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.用于控释给药的三甲基硅烷基改性介孔材料新型载体的研究
J Control Release. 2006 Aug 10;114(1):41-6. doi: 10.1016/j.jconrel.2006.05.006. Epub 2006 Jun 19.
7
Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.溶胶-凝胶法合成多功能、具有分级孔隙结构的二氧化硅/磷灰石复合材料。
Biomaterials. 2005 Dec;26(34):6827-35. doi: 10.1016/j.biomaterials.2005.05.002.
8
Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.具有控制药物释放性能的杂化有机-无机硅胶载体。
Chemistry. 2009 Nov 9;15(44):12043-9. doi: 10.1002/chem.200900603.
9
Freeze-dried and spray-dried zinc-containing silica microparticles entrapping insulin.包载胰岛素的冻干和喷雾干燥含锌二氧化硅微粒。
J Biomater Appl. 2014 Apr;28(8):1190-9. doi: 10.1177/0885328213501216. Epub 2013 Aug 28.
10
Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.多孔中空二氧化硅纳米颗粒作为布洛芬向小肠控释给药的载体。
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3139-44. doi: 10.1166/jnn.2006.410.

引用本文的文献

1
Mesoporous Silica Particles as Drug Delivery Systems-The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes.介孔二氧化硅颗粒作为药物递送系统——负载方法的现状及监测这些过程的分析技术的最新进展
Pharmaceutics. 2021 Jun 24;13(7):950. doi: 10.3390/pharmaceutics13070950.